Search

Melvyn I Marquis

Examiner (ID: 16161)

Most Active Art Unit
1501
Art Unit(s)
1402, 1505, 1503, 1501, 1712, 2200, 1754, 1401
Total Applications
2620
Issued Applications
2300
Pending Applications
26
Abandoned Applications
294

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18537882 [patent_doc_number] => 20230242985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => METHOD AND KIT FOR DETERMINING THE TISSUE OR CELL ORIGIN OF DNA [patent_app_type] => utility [patent_app_number] => 18/169821 [patent_app_country] => US [patent_app_date] => 2023-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23896 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 247 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18169821 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/169821
METHOD AND KIT FOR DETERMINING THE TISSUE OR CELL ORIGIN OF DNA Feb 14, 2023 Pending
Array ( [id] => 17156487 [patent_doc_number] => 20210317538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-14 [patent_title] => DETECTING PANCREATIC HIGH-GRADE DYSPLASIA [patent_app_type] => utility [patent_app_number] => 17/347027 [patent_app_country] => US [patent_app_date] => 2021-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25377 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17347027 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/347027
DETECTING PANCREATIC HIGH-GRADE DYSPLASIA Jun 13, 2021 Pending
Array ( [id] => 17112256 [patent_doc_number] => 20210292853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-23 [patent_title] => DETECTION OF CLDN18-ARHGAP6 FUSION GENE OR CLDN18-ARHGAP26 FUSION GENE IN PANCREATIC CANCER [patent_app_type] => utility [patent_app_number] => 17/336935 [patent_app_country] => US [patent_app_date] => 2021-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16322 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17336935 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/336935
DETECTION OF CLDN18-ARHGAP6 FUSION GENE OR CLDN18-ARHGAP26 FUSION GENE IN PANCREATIC CANCER Jun 1, 2021 Pending
Array ( [id] => 18170602 [patent_doc_number] => 20230037213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-02 [patent_title] => CHROMOSOME SEGMENT DERIVED FROM GOSSYPIUM ANOMALUM (G. ANOMALUM) LEADING TO LETHAL PHENOTYPE IN GOSSYPIUM HIRSUTUM (G. HIRSUTUM), AND MOLECULAR MARKERS THEREOF [patent_app_type] => utility [patent_app_number] => 17/783664 [patent_app_country] => US [patent_app_date] => 2021-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5152 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17783664 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/783664
CHROMOSOME SEGMENT DERIVED FROM GOSSYPIUM ANOMALUM (G. ANOMALUM) LEADING TO LETHAL PHENOTYPE IN GOSSYPIUM HIRSUTUM (G. HIRSUTUM), AND MOLECULAR MARKERS THEREOF Jun 1, 2021 Pending
Array ( [id] => 17482701 [patent_doc_number] => 20220090205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => METHODS FOR DIAGNOSING AND TREATING CANCER BY MEANS OF THE EXPRESSION STATUS AND MUTATIONAL STATUS OF NRF2 AND DOWNSTREAM TARGET GENES OF SAID GENE [patent_app_type] => utility [patent_app_number] => 17/335526 [patent_app_country] => US [patent_app_date] => 2021-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28478 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17335526 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/335526
METHODS FOR DIAGNOSING AND TREATING CANCER BY MEANS OF THE EXPRESSION STATUS AND MUTATIONAL STATUS OF NRF2 AND DOWNSTREAM TARGET GENES OF SAID GENE May 31, 2021 Pending
Array ( [id] => 17274857 [patent_doc_number] => 20210381055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-09 [patent_title] => METHODS OF DETECTING AND TREATING MULTIPLE SYSTEM ATROPHY [patent_app_type] => utility [patent_app_number] => 17/334683 [patent_app_country] => US [patent_app_date] => 2021-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16926 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17334683 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/334683
METHODS OF DETECTING AND TREATING MULTIPLE SYSTEM ATROPHY May 27, 2021 Pending
Array ( [id] => 18837927 [patent_doc_number] => 11845990 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-12-19 [patent_title] => Prediction of sleep parameter and response to sleep-inducing compound based on PER3 VNTR genotype [patent_app_type] => utility [patent_app_number] => 17/327102 [patent_app_country] => US [patent_app_date] => 2021-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 3917 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17327102 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/327102
Prediction of sleep parameter and response to sleep-inducing compound based on PER3 VNTR genotype May 20, 2021 Issued
Array ( [id] => 17067643 [patent_doc_number] => 20210269858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-02 [patent_title] => METHODS FOR DETECTING AND SEQUENCING A TARGET NUCLEIC ACID [patent_app_type] => utility [patent_app_number] => 17/319907 [patent_app_country] => US [patent_app_date] => 2021-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33607 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -38 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17319907 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/319907
METHODS FOR DETECTING AND SEQUENCING A TARGET NUCLEIC ACID May 12, 2021 Pending
Array ( [id] => 16992253 [patent_doc_number] => 20210230673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => ASSAYS FOR DETECTING MULTIPLE TICK-BORNE PATHOGENS [patent_app_type] => utility [patent_app_number] => 17/228749 [patent_app_country] => US [patent_app_date] => 2021-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18827 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17228749 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/228749
ASSAYS FOR DETECTING MULTIPLE TICK-BORNE PATHOGENS Apr 12, 2021 Pending
Array ( [id] => 16992189 [patent_doc_number] => 20210230609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => Solute Carrier Family 14 Member 1 (SLC14A1) Variants And Uses Thereof [patent_app_type] => utility [patent_app_number] => 17/225405 [patent_app_country] => US [patent_app_date] => 2021-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40227 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17225405 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/225405
Solute Carrier Family 14 Member 1 (SLC14A1) Variants And Uses Thereof Apr 7, 2021 Pending
Array ( [id] => 17007534 [patent_doc_number] => 20210238695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-05 [patent_title] => METHODS OF MAST CELL TUMOR PROGNOSIS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/216170 [patent_app_country] => US [patent_app_date] => 2021-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26344 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17216170 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/216170
METHODS OF MAST CELL TUMOR PROGNOSIS AND USES THEREOF Mar 28, 2021 Pending
Array ( [id] => 16948533 [patent_doc_number] => 20210207224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => DETECTING BREAST CANCER [patent_app_type] => utility [patent_app_number] => 17/205796 [patent_app_country] => US [patent_app_date] => 2021-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30827 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 215 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17205796 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/205796
DETECTING BREAST CANCER Mar 17, 2021 Pending
Array ( [id] => 16932862 [patent_doc_number] => 20210198751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-01 [patent_title] => COMPOSITIONS AND METHODS FOR DETECTING MUTATIONS IN JAK2 NUCLEIC ACID [patent_app_type] => utility [patent_app_number] => 17/204227 [patent_app_country] => US [patent_app_date] => 2021-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12563 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17204227 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/204227
COMPOSITIONS AND METHODS FOR DETECTING MUTATIONS IN JAK2 NUCLEIC ACID Mar 16, 2021 Pending
Array ( [id] => 16978026 [patent_doc_number] => 20210222263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => CROSS-ASSEMBLY PHAGE DNA SEQUENCES, PRIMERS AND PROBES FOR PCR-BASED IDENTIFICATION OF HUMAN FECAL POLLUTION SOURCES [patent_app_type] => utility [patent_app_number] => 17/201403 [patent_app_country] => US [patent_app_date] => 2021-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5264 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17201403 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/201403
CROSS-ASSEMBLY PHAGE DNA SEQUENCES, PRIMERS AND PROBES FOR PCR-BASED IDENTIFICATION OF HUMAN FECAL POLLUTION SOURCES Mar 14, 2021 Pending
Array ( [id] => 16978019 [patent_doc_number] => 20210222256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => PANCREATIC CANCER [patent_app_type] => utility [patent_app_number] => 17/179990 [patent_app_country] => US [patent_app_date] => 2021-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16001 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17179990 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/179990
PANCREATIC CANCER Feb 18, 2021 Pending
Array ( [id] => 16885832 [patent_doc_number] => 20210172027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-10 [patent_title] => DETECTING BREAST CANCER [patent_app_type] => utility [patent_app_number] => 17/178110 [patent_app_country] => US [patent_app_date] => 2021-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45110 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 329 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17178110 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/178110
DETECTING BREAST CANCER Feb 16, 2021 Pending
Array ( [id] => 16901220 [patent_doc_number] => 20210180136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF EPILEPSY [patent_app_type] => utility [patent_app_number] => 17/248798 [patent_app_country] => US [patent_app_date] => 2021-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40075 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -52 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17248798 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/248798
Compositions and methods for diagnosis and treatment of epilepsy Feb 7, 2021 Issued
Array ( [id] => 19258292 [patent_doc_number] => 12018338 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-25 [patent_title] => Compositions and methods for detection of [patent_app_type] => utility [patent_app_number] => 17/155831 [patent_app_country] => US [patent_app_date] => 2021-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11992 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17155831 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/155831
Compositions and methods for detection of Jan 21, 2021 Issued
Array ( [id] => 17272801 [patent_doc_number] => 20210378999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-09 [patent_title] => METHODS FOR TREATING NEUROBLASTOMA [patent_app_type] => utility [patent_app_number] => 17/147697 [patent_app_country] => US [patent_app_date] => 2021-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36700 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17147697 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/147697
METHODS FOR TREATING NEUROBLASTOMA Jan 12, 2021 Abandoned
Array ( [id] => 16728199 [patent_doc_number] => 20210095346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-01 [patent_title] => METHOD TO PREDICT HERITABLE CANINE NON-CONTACT CRUCIATE LIGAMENT RUPTURE [patent_app_type] => utility [patent_app_number] => 17/112608 [patent_app_country] => US [patent_app_date] => 2020-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20370 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17112608 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/112608
METHOD TO PREDICT HERITABLE CANINE NON-CONTACT CRUCIATE LIGAMENT RUPTURE Dec 3, 2020 Pending
Menu